Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 1 1

Status

Unknown 3Completed 3Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Hemorrhage 6Leiomyoma 3Hematologic Neoplasms 3Urinary Bladder Neoplasms 2Seizures 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasms 2Menorrhagia 2Urologic Diseases 1Urinary Tract Infections 1Urinary Retention 1Thromboembolism 1Thrombocytopenia 1Staphylococcal Infections 1Spasm 1Sleep Initiation and Maintenance Disorders 1Seroma 1Sepsis 1Schizophrenia, Treatment-Resistant 1Schizophrenia 1Retinitis 1Renal Insufficiency, Chronic 1Pulmonary Arterial Hypertension 1Prostatic Neoplasms 1Postoperative Complications 1Pneumonia 1Patient Satisfaction 1Pain 1Osteosarcoma 1

Interventions

estradiol, norethindrone drug combination 9asoprisnil 9Uterine Myomectomy 9telapristone acetate 8Uterine Artery Embolization 8ulipristal acetate 7relugolix 7elagolix 7Estradiol 7vilaprisan 5Norethindrone Acetate 5Mifepristone 5ulipristal 4linzagolix 4Leuprolide 4Tranexamic Acid 3Sodium Chloride 3Hysterectomy 3Gonadotropin-Releasing Hormone 3Embolization, Therapeutic 3cetrorelix 2Saline Solution 2Radiofrequency Ablation 2Progestins 2Lidocaine 2Letrozole 2Goserelin 2Endometrial Ablation Techniques 2Anesthesia, General 2pirfenidone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Leiomyoma × Tranexamic Acid × Clear all
NCT05517590 2024-05-24

Intravenous Tranexamic Acid and Intramyometrial Desmopressin Effect on Blood Loss During Laparoscopic Myomectomy.

Acibadem University

Phase NA Completed
102 enrolled

Hemorrhage, Leiomyoma

NCT02620748 2022-10-13

TA

George Washington University

Phase 1 Completed
60 enrolled

Hemorrhage, Leiomyoma

NCT03317795 2021-12-08

Treatment of Heavy Menstrual Bleeding in Women With Uterine Fibroids

Mayo Clinic

Phase 4 Completed
18 enrolled 13 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡